Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development.
about
Escherichia coli in Europe: an overviewInvestigational antimicrobial agents of 2013.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002.Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughterDifferent patterns in use of antibiotics for lower urinary tract infection in institutionalized and home-dwelling elderly: a register-based study.A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.Normalized resistance interpretation, the NRI method: Review of NRI disc test applications and guide to calculations.Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Application of the Vertex Exchange Method to estimate a semi-parametric mixture model for the MIC density of Escherichia coli isolates tested for susceptibility against ampicillin.Bayesian estimation of multivariate normal mixtures with covariate-dependent mixing weights, with an application in antimicrobial resistance monitoring.Bacterial sepsis following prostatic biopsy.Drug Resistance Patterns of Escherichia coli in Ethiopia: A Meta-Analysis.Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins
P2860
Q27015697-A2BE962D-0EAC-4829-AD72-1AF9E349D30BQ34375204-BB054977-F31C-4059-ADB4-21B677627CBBQ35482558-A44F4665-A518-4095-9A47-91F16C9376D1Q35979592-66308E51-F400-462E-8A1C-7395CC944B1BQ37068754-F846E0DC-DCC4-4ECA-AC27-679D397B176BQ38038035-75DF752E-FEB7-4D62-82DA-6A478F1C5923Q38635832-4107BF0D-D6C4-434D-8EE8-EBBFE9312F55Q39012323-9F698A5F-11E4-4EBF-90A3-A5D4BF490870Q41428630-D850C2FD-C382-4477-B3E9-6ECFCC8645FAQ41788804-A9B616E5-236F-4B8F-A3E4-E45311117F80Q45200010-D3D47876-04C1-41CB-92EE-C0E02BA574C9Q47690113-8B77C18A-40D8-474A-B068-913F6B818DDDQ54341490-7C4E3908-1B19-4FE1-BE60-457CA53B516DQ55045456-526AEF9E-9741-4AA7-B7E6-8456827D6005Q58798150-B78846D9-14C1-49CB-951F-5DB4A889DD22
P2860
Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial resistance 1979- ...... a coli resistance development.
@en
Antimicrobial resistance 1979- ...... a coli resistance development.
@nl
type
label
Antimicrobial resistance 1979- ...... a coli resistance development.
@en
Antimicrobial resistance 1979- ...... a coli resistance development.
@nl
prefLabel
Antimicrobial resistance 1979- ...... a coli resistance development.
@en
Antimicrobial resistance 1979- ...... a coli resistance development.
@nl
P2860
P921
P1476
Antimicrobial resistance 1979- ...... a coli resistance development.
@en
P2093
Göran Kronvall
P2860
P304
P356
10.1111/J.1600-0463.2010.02660.X
P577
2010-09-01T00:00:00Z